The neural activity assessments showed that bidentatide prevented primary cultured hippocampal neurons from NMDA-induced cell damage through inhibiting NR2B-containing NMDA receptors, suggesting its potential pharmaceutical applications in the treatment of nervous system disorders. This evidence concerns the gene GRIN2B and nervous system disorder.